New BA.3.2 Covid Variant Detected Across the United States
A new and highly mutated Covid variant, designated as BA.3.2, is quietly spreading throughout the United States, prompting close monitoring by the Centers for Disease Control and Prevention. This variant first emerged in South Africa in November 2024, and scientists are increasingly concerned that it may be significantly more adept at bypassing immune defenses, particularly the protection offered by the 2025-2026 Covid vaccines.
Genetic Mutations and Immune Evasion Concerns
The variant's spike protein, which vaccines train the body to recognize and combat, has undergone approximately 75 mutations. This extensive genetic alteration makes BA.3.2 appear as an entirely new threat to the immune system when compared to other recent strains. As of mid-March 2026, BA.3.2 has been identified in six travelers, three airplane wastewater samples, over two dozen patients, and 260 wastewater sites across 29 states and Puerto Rico. Overall, it accounts for a small fraction, about half a percent, of recent virus sequences, according to the latest CDC data.
Wastewater surveillance often provides the first indication that a virus is gaining a foothold in communities. In this instance, it detected BA.3.2 weeks before physicians observed it in patients. Detections of BA.3.2 began climbing in Europe last autumn, reaching roughly 30 percent of cases in Denmark, Germany, and the Netherlands. While it has not yet become dominant in the US, its ability to spread alongside other more prevalent variants suggests it has been mutating for an extended period.
CDC Surveillance and Early Detection Efforts
The CDC is actively monitoring the spread of BA.3.2 through testing international travelers, sampling airplane wastewater, and overseeing sewers nationwide. These systems captured the variant's arrival in the US in June 2025, months before it appeared in hospitals. On June 27, 2025, BA.3.2 was identified for the first time in the US at San Francisco International Airport in California, from a respiratory specimen collected from an individual returning from the Netherlands.
Reports started increasing in September 2025, but because many countries lack sophisticated surveillance tools necessary for closely tracking variants, these detections likely underrepresent the actual geographic extent of spread, according to the CDC. Wastewater surveillance in the US picked it up in Rhode Island that November, months before clinical cases emerged. The first patients were reported in early January 2026, involving two older hospitalized adults with underlying conditions and a young child, all of whom survived.
Laboratory Studies and Vaccine Efficacy
Two laboratory studies found that BA.3.2 does not bind as effectively to human cells as other variants do, and this weakness may be hindering its ability to spread more rapidly. Despite BA.3.2 potentially being better at evading immunity, current vaccines still offer protection against severe disease. The current Covid vaccine, updated for the 2025-26 season, performs well against the dominant JN.1 strains still circulating.
In a lab study comparing seven variants, it performed worst against BA.3.2. This suggests the vaccine may offer reduced protection against this particular variant, though real-world data is still required for confirmation. BA.3.2 is genetically distinct from the JN.1 family of variants that have dominated in the US since early 2024. Compared to the strain used in current vaccines, BA.3.2 has about 70 to 75 mutations on its spike protein, with 20 in the part that attaches to human cells, 35 in a nearby region aiding infection and immune evasion, and the remaining changes scattered elsewhere.
Tracking and Global Spread
To track Covid variants, the CDC pulls data from three primary sources: national lab testing, travelers arriving at airports including volunteer nasal swabs and airplane wastewater, and a nationwide wastewater surveillance system monitoring about 1,450 sewer sites. When scientists identify a BA.3.2 sample, they analyze its genetic code, comparing it to current vaccines to assess changes. They use software to align sequences side by side, constructing family trees that illustrate how different versions are related.
Every detection is logged by location and date, enabling the CDC to map where it first appeared and how quickly it moves, providing officials with a real-time view of the evolving variant. By February 11, 2026, BA.3.2 had been identified in at least 23 countries, including four US travelers who tested positive through the Traveler-based Genomic Surveillance program after returning from Japan, Kenya, the Netherlands, and the United Kingdom.
Shift to Seasonal Public Health Concern
Covid has transitioned from a consistent viral threat to a seasonal public health concern alongside influenza and respiratory syncytial virus. In 2020 and 2021, the country often experienced waves of severe disease transmission, with thousands of patients dying daily. Now, the virus follows a predictable seasonal rhythm with far shorter peaks, thanks to highly effective vaccines and the antiviral drug Paxlovid.
Similar to influenza, Covid now tends to spike during colder months, from late autumn through early spring, when people gather indoors and the virus spreads more easily. Cases typically decline in summer. Most of the population now has some protection from a combination of vaccination, prior infection, or both. While this does not prevent everyone from becoming ill, it means most individuals who contract the virus will not require hospitalization.
